生物降解的聚合物微球配方的全长抗VEGF抗体贝瓦西祖马布持续眼内输送

Shwetha Iyer1,2, Cameron Lee2, Mansoor M Amiji3,4

  • 1Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA.

概括

研究人员为抗VEGF抗体贝瓦齐祖马布开发了缓释微球,用于治疗与年龄相关的黄斑变性 (AMD). 这种新的注射方法可以减少治疗频率,并改善患者的遵守性.